BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37115817)

  • 1. Microneedle-Mediated Transcutaneous Immunization: Potential in Nucleic Acid Vaccination.
    Wang H; Xu J; Xiang L
    Adv Healthc Mater; 2023 Sep; 12(23):e2300339. PubMed ID: 37115817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microneedle-based percutaneous immunity: a review].
    Li Y; Wang J; Jin Z; Wan W; Bai X; Hu C; Li Y; Xin W; Kang L; Yang H; Wang J; Gao S
    Sheng Wu Gong Cheng Xue Bao; 2022 Sep; 38(9):3301-3315. PubMed ID: 36151801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
    Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
    Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The success of microneedle-mediated vaccine delivery into skin.
    Marshall S; Sahm LJ; Moore AC
    Hum Vaccin Immunother; 2016 Nov; 12(11):2975-2983. PubMed ID: 27050528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcutaneous immunization using microneedles and cubosomes: Mechanistic investigations using Optical Coherence Tomography and Two-Photon Microscopy.
    Rattanapak T; Birchall J; Young K; Ishii M; Meglinski I; Rades T; Hook S
    J Control Release; 2013 Dec; 172(3):894-903. PubMed ID: 23978683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
    Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
    Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances of microneedles in hormone delivery.
    Nguyen TT; Nguyen TTD; Tran NM; Vo GV
    Biomed Pharmacother; 2022 Jan; 145():112393. PubMed ID: 34773762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microneedles enable the development of skin-targeted vaccines against coronaviruses and influenza viruses.
    Nguyen TT; Nguyen TTD; Tran NM; Nguyen HT; Vo GV
    Pharm Dev Technol; 2022 Jan; 27(1):83-94. PubMed ID: 34802372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microneedle-mediated transdermal drug delivery for treating diverse skin diseases.
    Yang D; Chen M; Sun Y; Jin Y; Lu C; Pan X; Quan G; Wu C
    Acta Biomater; 2021 Feb; 121():119-133. PubMed ID: 33285323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination.
    Balmert SC; Carey CD; Falo GD; Sethi SK; Erdos G; Korkmaz E; Falo LD
    J Control Release; 2020 Jan; 317():336-346. PubMed ID: 31756393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen.
    Cole G; Ali AA; McErlean E; Mulholland EJ; Short A; McCrudden CM; McCaffrey J; Robson T; Kett VL; Coulter JA; Dunne NJ; Donnelly RF; McCarthy HO
    Acta Biomater; 2019 Sep; 96():480-490. PubMed ID: 31299353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
    Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA
    J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring new frontiers in drug delivery with minimally invasive microneedles: fabrication techniques, biomedical applications, and regulatory aspects.
    Sultana N; Waheed A; Ali A; Jahan S; Aqil M; Sultana Y; Mujeeb M
    Expert Opin Drug Deliv; 2023 Jun; 20(6):739-755. PubMed ID: 37038271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural design strategies of microneedle-based vaccines for transdermal immunity augmentation.
    Xu G; Mao Y; Jiang T; Gao B; He B
    J Control Release; 2022 Nov; 351():907-922. PubMed ID: 36216175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microneedle-Based Vaccine Delivery: Review of an Emerging Technology.
    Mansoor I; Eassa HA; Mohammed KHA; Abd El-Fattah MA; Abdo MH; Rashad E; Eassa HA; Saleh A; Amin OM; Nounou MI; Ghoneim O
    AAPS PharmSciTech; 2022 Apr; 23(4):103. PubMed ID: 35381906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy.
    Duong HTT; Yin Y; Thambi T; Nguyen TL; Giang Phan VH; Lee MS; Lee JE; Kim J; Jeong JH; Lee DS
    Biomaterials; 2018 Dec; 185():13-24. PubMed ID: 30216806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.
    Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC
    Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous immunization: an evolving paradigm in influenza vaccines.
    Gill HS; Kang SM; Quan FS; Compans RW
    Expert Opin Drug Deliv; 2014 Apr; 11(4):615-27. PubMed ID: 24521050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microneedle-based insulin transdermal delivery system: current status and translation challenges.
    Zhao J; Xu G; Yao X; Zhou H; Lyu B; Pei S; Wen P
    Drug Deliv Transl Res; 2022 Oct; 12(10):2403-2427. PubMed ID: 34671948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.